Literature DB >> 4130633

Modification of in vitro immune lymphocyte-target cell interaction by some biologically active drugs.

B D Brondz, A E Snegiröva, Y A Rassulin, O G Shamborant.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4130633     DOI： 10.1016/0019-2791(73)90006-2

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  6 in total

1.  T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo.

Authors:  C M Henningsson; S Selvaraj; G D MacLean; M R Suresh; A A Noujaim; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Enhancement of lymphocyte response to PHA by lysosomal enzymes from polymorphonuclear leukocytes of RA joint fluid. I. Biological effect on T lymphocyte function.

Authors:  T Abe; C Morimoto; T Toguchi; M Kiyotaki; M Homma
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

3.  Characteristics of the leucocyte-aggregation assay for cell-mediated immunity.

Authors:  B H Tom; L O Huang; M M Jakstys; B D Kahan
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

4.  Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition.

Authors:  J A Barbosa; J Santos-Aguado; S J Mentzer; J L Strominger; S J Burakoff; P A Biro
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

5.  Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes.

Authors:  S A Goldstein; M F Mescher
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

6.  Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.

Authors:  H G Remold
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.